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Abstract Trimetazidine (TMZ), a 
potent antioxidant agent, has been 
used to protect the myocardium, 
liver and kidney from ischemia re- 
perfusion (IR) injury. We investigat- 
ed the effect of TMZ, a cellular anti- 
ischemic agent and a free radical 
scavenger, on 60 rnin of warm intes- 
tinal IR injury in rats. Sprague- 
Dawley rats were divided into three 
groups: a sham-operated group (no 
IR injury, n = S), an ischemic control 
group (control, n = 8), and a TMZ- 
treated group (3 mg/kg, y1 = 8). Mal- 
ondialdehyde (MDA) levels, my- 
eloperoxidase (MPO) activity, and 
mucosal damage were investigated 
after 120 min of reperfusion. MDA 
levels and MPO activity were more 
elevated and histopathological 
damage more severe in the control 
group than in the sham group 
( P  < 0.05). MDA levels and MPO 
activity were lower and there was 
less histopathological damage in the 
TMZ group than in the control 
group ( P  < 0.0s). Accumulation of 
lipid peroxidation products and 
neutrophils in mucosal tissues were 
significantly inhibited by TMZ 
treatment. We conclude that pre- 
treatment of rats with TMZ before 
intestinal ischemia attenuates but 
does not prevent, histological dam- 
age. 
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Introduction 
Free oxygen radical generation has been implicated as a 
major mediator in intestinal ischemia-reperfusion (IR) 
injury [4, 5 ,  16, 18, 241. Lipid peroxidation and protein 
oxidation caused by free oxygen radicals result in struc- 
tural and functional cell damage. Established sources 
of oxygen radical production are the hypoxanthinelxan- 
thine oxidase system and neutrophil granulocytes. Most 
of the free radicals are produced as a result of the accu- 
mulation of hypoxanthine and the formation of xan- 
thine oxidase during the ischemic period following re- 
perfusion. Superoxide radicals produced in the xanthine 
oxidase reaction trigger neutrophil infiltration into is- 
chemic tissues. The importance of neutrophils in the de- 
velopment of IR injury in various organs such as the liv- 
er and intestine has been shown [4, 12, 16, 21, 241. Acti- 
vated polymorpbonuclear leukocytes (PMN) release 
substances such as oxygen free radicals, arachidonic 
acid products, and proteolytic enzymes such as elastase. 
Intestinal mucosal damage can be prevented by mono- 
clonal antibody blocking leukocyte adherence to endo- 
thelial cells 111,241. 
Free radical scavengers such as superoxide dismu- 
tase, catalase, and allopurinol have reduced the severity 
of intestinal IR injury [5,  14, 18, 241. Trimetazidine 
(TMZ), a potent antioxidant agent, has been used to 
protect IR injury of the myocardium, liver, and kidney 
[7,17,20,22]. However, there is no report on the use of 
TMZ in intestinal IR injury. 
In this study, we have investigated the effect of TMZ, 
a cellular anti-ischemic agent and a free radical scaven- 
ger, on 60 mill of warm intestinal IR injury in rats. 
109 
Fig. 1 Severe mucosal damage 
after IR injury in the control 
group (grade 4, HE x 100) 
Materials and methods 
This study was carried out on male Sprague-Dawley rats weighing 
220-250 g. Rats were kept under standardized conditions for 
food, water, light, and temperature. All animals were fed standard 
rat chow and water ad libitum and were given only water for 12 h 
before surgery. 
After an overnight fast, the rats were anesthetized with an in- 
tramuscular injection of SO mgikg ketamine hydrochloride (Keta- 
lar, Parke-Davis, Eczacbay, Turkey) and 10 mg/kg xylazine (Rom- 
pun, Bayer, Leverkusen, Germany), and the right internal jugular 
vein was catheterized using 24-gauge catheters. After skin shaving 
and preparation of the abdominal wall with 10% povidone-iodine 
solution, a midline laparotomy was performed. The small bowel 
was exteriorized and the ligament of Treitz cut to expose the supe- 
rior mesenteric artery (SMA). The SMA was dissected. After hep- 
arinization (80 IU). an atraumatic microvascular clamp (Aesculap 
BH 21) was then placed across the SMA just after its origin from 
the aorta for occlusion, avoiding occlusion of the superior mesen- 
teric vein. Mesenteric ischemia was Confirmed when the mesenter- 
ic pulsations were lost and the intestines became pale. The bowel 
was returned to the abdominal cavity, and the incision was closed 
with interrupted atraumatic 410 silk sutures. After 60 min of is- 
chemia, a relaparotomy was performed and the microvascular 
clamp on  the SMA was removed for 120 min of reperfusion. Mes- 
enteric reperfusion was confirmed with the restoration of pulsation 
and color. The bowel was then returned to the abdominal cavity 
once more, and the incision was closed with 4/0 silk sutures, The 
bowel was left in the abdomen during IR. The sham operation in- 
volved the same technique and exposure without clipping of the 
SMA. At the end of 120 min, the animals were sacrificed. 
Ileal tissue samples were obtained and stored at -78°C after 
immersion in liquid nitrogen for later determinations of tissue mal- 
ondialdehyde (MDA) and myeloperoxidase (MPO) levels. A 5-cm 
ileal segment was fixed in 10 % formaldehyde for histopathological 
examination. Throughout the study, 10 ml/kg Ringer’s lactate was 
infused from the internal jugular catheter. 
Experimental design 
Three groups of animals were used in this study. Group I ,  the 
sham-operated group (sham, n = X), underwent laparotomy with- 
out IR injury. Group 2, the ischemic control group (control, n = 
X), underwent laparotomy plus 60 min of ischemia and 120 min of 
reperfusion; they received only intravenous Ringer’s lactate during 
IR injury. Group 3, the trimetazidine-treated group (TMZ, n = X), 
received 3 mg/kg TMZ (Vastarel, Servier, France) intravenously 
10 min before the induction of ischemia. 
Histopathological evaluation 
The tissue specimens were fixed in 10% formaldehyde. Samples 
of intestine were embedded in paraffin, sectioned, and stained 
with hematoxylin-eosin (HE). They were then submitted for his- 
topathological evaluation, which was performed in a blinded 
fashion by two pathologists. Mucosal lesions were graded on a 
scale from 0 to S as described by Chiu et a1 131. Grade 0 indicated 
normal mucosal villi; grade 1, the development of subepithelial 
Gruenhagen’s space, usually at the apex of the villus, often with 
capillary congestion; grade 2, extension of the subepithelial space 
with moderate lifting of epithelial layer from the lamina propria; 
grade 3, massive epithelial lifting with a few denuded villi; grade 
4, denuded villi with exposed dilated capillaries; and grade 5,  di- 
gestion and disintegration of lamina propria, hemorrhage, and ul- 
ceration. 
MDA and MPO determinations 
The levels of MDA were determined in intestinal rnucosa hornoge- 
nized in the ratio of 1:lO (weight: volume) in 1.1s YO cold KCI solu- 
tion following the thiobarbituric acid method, and the results were 
obtained in nmol/g tissue weight [13]. 
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Tissue-associated MPO activity in intestinal mucosa was deter- 
mined using the method of Grisham et al [XI .  Some 300-mg sam- 
ples of intestinal mucosa were homogenized in 5 ml of ice-cold 
0.02 M ethylenediaminetetra-acetic acid (pH 4.7) for 60 s. Five 
milliliters of mucosal homogenate was centrifuged at 20000 revo- 
lutions per minute (rpm) for 15 min at 4°C to pellet the insoluble 
cellular debris. The supernatant, which contained less than 5 YO of 
total MPO activity, was discarded. The pellet was then rehomoge- 
nized in an equivalent volume of 0.05 M potassium phosphate buff- 
er (pH 6.0) containing 0.5 YO hexadecyltrimethylammonium bro- 
mide (HETAB). MPO activity was assessed by measuring the 
H,O,-dependent oxidation of 0-dianisidin. One unit of enzyme ac- 
tivity was defined as the amount of MPO present that caused a 
change in absorbance of l.0imin at 410 nm and 37°C [6]. 
Statistics 
The results were evaluated using a one-way analysis of variance, 
and the differences among the groups were analyzed with the Tu- 
key HSD test, except for histopathological values. For the latter, 
differences among the groups were evaluated with the Mann- 
Whitney U-test. All values were expressed as mean SD. Differ- 
ences were considered significant when P was less than 0.05. 
Results 
In the sham group, the results of the histopathological 
examinations of the small intestinal epithelium and villi 
were normal. The specimens from this group were clas- 
sified as grade 0-1 according to the Chiu classification. 
In the control group, grade 3-5 histopathological dam- 
age was detected (Fig. 1). In addition, PMN infiltration 
was detected in 50% of the specimens. In the TMZ 
group, grade 1-2 damage was detected (Fig.2). In this 
group, two specimens were detected as grade 5.  Howev- 
er, PMN infiltration was not seen. 
Mucosal injury scores were 0.5 -t 0.53, 4.25 k 0.70, 
and 2.2.5 -t 1.75 in the sham, control, and TMZ groups, 
respectively (Fig. 3). More intense histopathological 
damage was observed in the control group than in the 
sham group ( P  < 0.01). The histopathological injury in 
the TMZ group was significantly lower than in the con- 
trol group ( P  < 0.05). Pretreatment with TMZ attenuat- 
ed, but did not prevent, intestinal IR injury. 
The mean MDA levels were 16.42 -t 2.44, 30.62 -t 
8.46, and 17.66 k 3.01 nmol/g tissue in the sham, control, 
and TMZ groups, respectively (Fig. 4). The difference 
between the sham and TMZ groups was not significant, 
but the MDA levels in the control group were signifi- 
cantly elevated in comparison to those in the sham and 
TMZ groups ( P  < 0.05). 
MPO levels were 0.74 t 0.09, 4.94 * 1.91, and 0.57 t 
0.23 U/g tissue in the sham, control, and TMZ groups, 
respectively (Fig. 5) .  In the control group, the MPO lev- 
el was significantly higher than in the other groups 
( P  < 0.05). Pretreatment with TMZ attenuated MPO 
levels after intestinal IR injury. 
Fig.2 Mild mucosal damage after IR injury in the TMZ group 
(grade 2, HE x 200) 
Discussion 
This study demonstrated that 120 min of reperfusion 
following 60 min of ischemia of the rat intestine caused 
severe mucosal damage. The pretreatment of rats with 
TMZ before intestinal ischemia attenuated, but did not 
prevent, histological damage from IR by inhibiting lipid 
peroxidation and neutrophil infiltration in the mucosal 
tissue. 
TMZ (1-(2,3,4-trimethoxy,benzyI) piperazine dihy- 
drochloride) is an anti-ischemic agent known to im- 
prove exercise tolerance and cardiac function in pa- 
tients with ischemic heart disease [2]. It has been shown 
that pretreatment with TMZ is effective in reducing the 
size of the infarct that developes in the blood-perfused 
rabbit model of myocardial ischemia [15]. Various ex- 
perimental studies have shown that TMZ preserves the 
intracellular concentration of adenosine triphosphate 
and inhibits the extracellular leakage of potassium dur- 
ing cellular ischemia. TMZ reduces intracellular accu- 
mulation of sodium and calcium and inhibits platelet ad- 
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hesion-aggregation, neutrophil infiltration, and the gen- 
eration or activity of oxygen-derived free radicals [l, 9, 
221. The potent antioxidant effect of TMZ has been 
demonstrated in myocardial, renal, and hepatic IR inju- 
ry [7, 17,20,22]. 
A significant increase in MDA levels has been ob- 
served in various organs including the liver, kidney, and 
intestine during IR injury [7,16,19,23,24]. In this study, 
the elevated levels of MDA in the control group sup- 
ported the notion that lipid peroxidation processes oc- 
cur during IR injury. The decrease in the level of MDA 
in the TMZ group, as compared with the control group, 
indicated that lipid peroxidation was inhibited by this 
agent. Our previous study showed that TMZ significant- 
ly reduced lipid peroxidation after 75 min of warm renal 
ischemia followed by reperfusion injury [17]. Grekas 
et al. have also described the inhibition of lipid peroxi- 
dation by TMZ in renal IR injury [7]. 
We used MPO activity as an index of PMN accumu- 
lation in the intestine in this study. It is directly propor- 
tional to the numbers of neutrophils seen in histological 
sections of intestine tissue, and is therefore regarded as 
a reliable index of neutrophil infiltration [4, 5, 8, 24, 
251. It has been reported that MPO activity in intestinal 
tissue increases threefold after 60 min of intestinal is- 
chemia, and eight to ninefold after 60min of reperfu- 
sion [12]. In this study, MPO activity in the mucosal tis- 
sue was higher in the control group, reflecting neutro- 
phi1 infiltration after reperfusion, than in the sham 
group. Our results are in accordance with those in the 
literature [5,  12, 16, 19, 251. The significant decrease in 
MPO activity in the TMZ group led us to believe that 
TMZ decreased leukocyte recruitment. However, it 
does not demonstrate an inhibition of PMN activation 
in postischemic tissue. The reperfusion-induced recruit- 
ment of leukocytes can be largely prevented by pre- 
treatment with superoxide dismutase or allopurinol [8, 
251. Previous studies have demonstrated that resident 
leukocytes may play a pivotal role in the pathogenesis 
of intestinal IR injury [lo, 111. 
Histological damage that occurs after intestinal IR is 
characterized by shortening of the villus length, loss of 
villus epithelium, necrosis, and invasion of inflammato- 
ry cells [12,16,19,23]. In the present study, we observed 
that 60 min of intestinal ischemia following 120 min of 
reperfusion produced severe mucosal injury and PMN 
infiltration in the rats. Pretreatment with TMZ attenu- 
ated the histological damage and PMN infiltration. 
This improvement might be due to the inhibition of neu- 
trophil accumulation. 
We conclude that pretreatment of rats with TMZ be- 
fore intestinal ischemia attenuates, but does not pre- 
vent, histological damage from IR by inhibiting lipid 
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